14093223

Source:http://linkedlifedata.com/resource/pubmed/id/14093223

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002744, umls-concept:C0149783
pubmed:dateCreated	1964-4-1
pubmed:keyword	http://linkedlifedata.com/resource/pubmed/keyword/ANABOLIC STEROIDS, http://linkedlifedata.com/resource/pubmed/keyword/ANOREXIA NERVOSA, http://linkedlifedata.com/resource/pubmed/keyword/BONE NEOPLASMS, http://linkedlifedata.com/resource/pubmed/keyword/BREAST NEOPLASMS, http://linkedlifedata.com/resource/pubmed/keyword/CORTISONE TOXICOLOGY, http://linkedlifedata.com/resource/pubmed/keyword/HYPERTHYROIDISM, http://linkedlifedata.com/resource/pubmed/keyword/INFECTION, http://linkedlifedata.com/resource/pubmed/keyword/INTESTINAL DISEASES, http://linkedlifedata.com/resource/pubmed/keyword/KIDNEY DISEASES, http://linkedlifedata.com/resource/pubmed/keyword/LIVER DISEASES, http://linkedlifedata.com/resource/pubmed/keyword/NEOPLASM METASTASIS, http://linkedlifedata.com/resource/pubmed/keyword/OSTEOPOROSIS, http://linkedlifedata.com/resource/pubmed/keyword/POSTOPERATIVE COMPLICATIONS, http://linkedlifedata.com/resource/pubmed/keyword/PROTEIN METABOLISM, http://linkedlifedata.com/resource/pubmed/keyword/THINNESS, http://linkedlifedata.com/resource/pubmed/keyword/TOXICOLOGIC REPORT, http://linkedlifedata.com/resource/pubmed/keyword/UREMIA
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0421110
pubmed:citationSubset	OM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anabolic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cortisone, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Steroids
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0031-0808
pubmed:author	pubmed-author:CAMANNIFF, pubmed-author:MOLINATTIG MGM
pubmed:issnType	Print
pubmed:volume	104
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	307-12
pubmed:dateRevised	2011-9-28
pubmed:meshHeading	pubmed-meshheading:14093223-Anabolic Agents, pubmed-meshheading:14093223-Anorexia Nervosa, pubmed-meshheading:14093223-Bone Neoplasms, pubmed-meshheading:14093223-Breast Neoplasms, pubmed-meshheading:14093223-Cortisone, pubmed-meshheading:14093223-Hyperthyroidism, pubmed-meshheading:14093223-Infection, pubmed-meshheading:14093223-Intestinal Diseases, pubmed-meshheading:14093223-Kidney Diseases, pubmed-meshheading:14093223-Liver Diseases, pubmed-meshheading:14093223-Neoplasm Metastasis, pubmed-meshheading:14093223-Osteoporosis, pubmed-meshheading:14093223-Postoperative Complications, pubmed-meshheading:14093223-Proteins, pubmed-meshheading:14093223-Steroids, pubmed-meshheading:14093223-Thinness, pubmed-meshheading:14093223-Toxicology, pubmed-meshheading:14093223-Uremia
pubmed:year	1963
pubmed:articleTitle	WHEN AND HOW SHOULD ANABOLIC STEROID THERAPY BE USED?
pubmed:publicationType	Journal Article